Written by Rita Laila Fussenegger Autoimmune diseases affect millions of people and often require lifelong treatment rather than true disease modification. Project EOS explores whether a modular CAAR-T cell therapy platform, supported by microgravity research, could help transform how autoimmune diseases are treated. By combining immunology, cell therapy, and space biotechnology, the initiative seeks to investigate new approaches to safety, efficacy, scalability, and accessibility for future therapies.
